Latest Share Chat

REMOVE ADS

SLN.L Share News (SLN)

SLN.L Information

There is currently no data for SLN

REMOVE ADS

SLN.L News

Silence ends bid talks

Shares in Silence Therapeutics have fallen by 15% after it admitted that bid talks had ended. AIM-quoted Silence originally said that it was in bid ...

Small caps round-up: Forte Energy, Discovery Metals Proximagen...

Uranium company Forte Energy has been testing for rare earth elements (REE) in Guinea and the latest assay results indicate "provide a higher level of...

Positive study for Silence

AIM-quoted Silence Therapeutics says that research shows that its lead RNA interference (RNAi) drug candidate, Atu027, prevents the spread of breast c...

London close: Second wind lifts Footsie higher

A strong start on Wall Street ensured Footsie finished with good gains having started the day on a strong footing. US shares moved ahead including ho...

London afternoon: Lloyds up as Daniels names exit date

Stocks gave up a proportion of their gains over the lunch time session despite expectations of a firm start on Wall Street. Part-nationalised banking...

London midday: US coast guard verdicts lifts BP

Investors are in an optimistic frame of mind ahead of the Federal Reserve's Federal Open Market Committee (FOMC) meeting tomorrow. The 'glass half ful...

Interdigm integration lifts losses at Silence

Bid target Silence Therapeutics said 2010 has been a pivotal year with the company making advances in the three areas it sees as the most important in...

Silence Therapeutics rockets on bid approach

Silence Therapeutics gained more than three quarters of its value Monday on news of a bid approach. The AIM-listed firm, involved in developing RNA i...